Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | CFTR | P13569 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | MYC | P01106 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18537273 | 0.96 | TSHR (0.53) | LMNATSHRNR4A2ALDH1A1HSD17B10 | |
| SCHEMBL3511611 | 0.90 | TSHR (0.57) | LMNATSHRALDH1A1HSD17B10CFTR | |
| SCHEMBL12313575 | 0.84 | CXCR5 (0.52) | LMNATSHRNR4A2ALDH1A1HSD17B10 | |
| SCHEMBL16959103 | 0.84 | TSHR (0.46) | LMNATSHRNR4A2ALDH1A1HSD17B10 | |
| SCHEMBL9726590 | 0.83 | KDM4E (0.52) | LMNAALDH1A1HSD17B10KDM4EHPGD | |
| SCHEMBL11678098 | 0.83 | TSHR (0.63) | LMNATSHRALDH1A1HSD17B10KDM4E | |
| SCHEMBL12569625 | 0.83 | NR4A2 (0.44) | LMNATSHRNR4A2ALDH1A1HSD17B10 | |
| SCHEMBL7197691 | 0.83 | ALDH1A1 (0.49) | LMNATSHRNR4A2ALDH1A1HSD17B10 | |
| SCHEMBL4955520 | 0.83 | TDP1 (0.54) | LMNATSHRNR4A2ALDH1A1HSD17B10 | |
| SCHEMBL23092927 | 0.82 | LMNA (0.50) | LMNATSHRALDH1A1HSD17B10CFTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3692101-B1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | ALFA INSTR S R L (IT) | 2022-01-12 | — | — | EP | claimed |
| EP-3692101-A1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | Alfa Instruments S.r.l. (IT) | 2020-08-12 | — | — | EP | claimed |
| WO-2019068935-A1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | ALFA INSTRUMENTS S.R.L. (IT) | 2019-04-11 | — | — | WO | claimed |
| CN-122037370-A | Conductive polypropylene composition, and preparation method and application thereof | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260108482-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | ESCIENT PHARMACEUTICALS INC (US) | 2026-04-23 | — | — | US | disclosed |
| CN-115380030-B | N-heteroarylalkyl-2- (heterocyclyl and heterocyclylmethyl) acetamide derivatives as SSTR4 agonists | 武田药品工业株式会社 | 2025-05-16 | — | — | CN | disclosed |
| CN-113939288-B | Modulators of MAS-related G protein receptor X4 and related products and methods | 伊赛恩特制药公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119614722-A | Screening method of novel dicyclo borate beta-lactamase inhibitor | 南京灿辰微生物科技有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20240300907-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | INCYTE CORPORATION | 2024-09-12 | — | — | US | disclosed |
| CN-117924555-A | Catalyst component, catalyst system, application of catalyst system and olefin polymerization method | 中国石油化工股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117924556-A | Spherical magnesium halide adduct and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-6406297-B1 | USED FOR DETECTING AND QUANTIFYING CHEMICAL, BIOCHEMICAL AND BIOLOGICAL SUBSTANCES AS ANALYTES IN RESEARCH AND DIAGNOSTIC MIXTURES. | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-06-18 | — | — | US | disclosed |
| US-6127356-A | MODULATING INTRA- OR EXTRACELLULAR LEVELS OF OXIDANTS SUCH AS SUPEROXIDE RADICALS, HYDROGEN PEROXIDE AND PEROXYNITRITES BY USING LOW MOLECULAR WEIGHT MIMETICS OF SUPEROXIDE DISMUTASE, CATALASE OR PEROXIDASE | DUKE UNIVERSITY (US) | 2000-10-03 | — | — | US | disclosed |
| EP-0831891-A4 | OXIDANT SCAVENGERS | UNIV DUKE (US) | 1999-02-03 | — | — | EP | disclosed |
| EP-0831891-A1 | OXIDANT SCAVENGERS | DUKE UNIVERSITY (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996040223-A1 | OXIDANT SCAVENGERS | DUKE UNIVERSITY (US) | 1996-12-19 | — | — | WO | disclosed |
| US-5234942-A | Treating allergic pulmonary disorders, asthma | ICI AMERICAS INC. (US) | 1993-08-10 | — | — | US | disclosed |
| US-4997844-A | Compounds for the treatment of allergic or inflammatory diseases or shock conditions | ICI AMERICAS INC. (US) | 1991-03-05 | — | — | US | disclosed |
| EP-0179619-B1 | HETEROCYCLIC AMIDES | ICI AMERICAS INC. (US) | 1990-09-05 | — | — | EP | disclosed |
| EP-0179619-A1 | Heterocyclic amides | ICI AMERICAS INC. (US) | 1986-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108482-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | MRGPRX4, MRGPRX1, MRGPRX2 | LMNA 3618/4885TSHR 34/4885NR4A2 179/4885 |
| US-20240300907-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | MRGPRX4, MRGPRX1, MRGPRX2 | LMNA 3209/4885TSHR 98/4885NR4A2 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.